MetaADEDB 2.0 @ LMMD
beraprost
(YTCZZXIRLARSET-VJRSQJMHSA-M)
Structure
SMILES
CC#CCC([C@@H](/C=C/[C@H]1[C@H](O)C[C@H]2[C@@H]1c1cccc(c1O2)CCCC(=O)[O-])O)C.[Na+]
Type(s)
Investigational
ATC code(s)
B01AC19
Molecular Formula:
C24H29NaO5
Molecular Weight:
420.474
Log P:
1.9512
Hydrogen Bond Acceptor:
5
Hydrogen Bond Donor:
2
TPSA:
89.82
CAS Number(s):
88430-50-6; 88475-69-8
Synonym(s)
1.
beraprost
2.
4-(1,2,3a,8b-tetrahydro-2-hydroxy-1-(3-hydroxy-4-methyloct-6-yne-1-enyl)-5-cyclopenta(b)benzofuranyl)butyrate
3.
TRK 100
4.
TRK-100
5.
beraprost sodium
External Link(s)
MeSHC048081
PubChem Compound23663404
CHEMBLCHEMBL435883
DrugBankDB05229
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Abdominal AbscessOFFSIDES
2AcidosisOFFSIDES
3Alanine Aminotransferase IncreasedOFFSIDES
4Altered state of consciousnessOFFSIDES
5AnorexiaOFFSIDES
6AnuriaOFFSIDES
7AsterixisOFFSIDES
8Atrial FlutterOFFSIDES
9Autoimmune thrombocytopeniaOFFSIDES
10Blood GlucoseOFFSIDES
11Blood alkaline phosphatase increasedOFFSIDES
12Blood creatine phosphokinase MBOFFSIDES
13Blood creatine phosphokinase increasedOFFSIDES
14Blood creatinine decreasedOFFSIDES
15Blood creatinine increasedOFFSIDES
16Blood glucose decreasedOFFSIDES
17Blood glucose fluctuationOFFSIDES
18Blood immunoglobulin EOFFSIDES
19Blood lactate dehydrogenase increasedOFFSIDES
20Blood phosphorus increasedOFFSIDES
21Blood potassium increasedOFFSIDES
22Blood pressure inadequately controlledOFFSIDES
23Blood urea increasedOFFSIDES
24Blood urine presentOFFSIDES
25Body TemperatureOFFSIDES
26Bone lesionOFFSIDES
27Brain natriuretic peptide increasedOFFSIDES
28Breast cancer recurrentOFFSIDES
29BronchiectasisOFFSIDES
30Bronchoscopy abnormalOFFSIDES
31CataplexyOFFSIDES
32CheilitisOFFSIDES
33Chemotherapeutic drug level increasedOFFSIDES
34Chronic respiratory failureOFFSIDES
35CirrhosisOFFSIDES
36Coagulation test abnormalOFFSIDES
37Cold sweatOFFSIDES
38Creatinine renal clearance decreasedOFFSIDES
39DehydrationOFFSIDES
40Dental abscessOFFSIDES
41Depressed Level of ConsciousnessOFFSIDES
42Disseminated Intravascular CoagulationOFFSIDES
43DyslaliaOFFSIDES
44DysuriaOFFSIDES
45EczemaOFFSIDES
46Electrocardiogram ST-T changeOFFSIDES
47EncephalitisOFFSIDES
48Eosinophilic PneumoniaOFFSIDES
49EpididymitisOFFSIDES
50Erythema MultiformeOFFSIDES
51ErythemaOFFSIDES
52Extremity necrosisOFFSIDES
53Feeling ColdOFFSIDES
54Femoral artery occlusionOFFSIDES
55Gamma-Glutamyltransferase IncreasedOFFSIDES
56Gastric LavageOFFSIDES
57Gastrointestinal perforationOFFSIDES
58Hepatic congestionOFFSIDES
59Histiocytosis haematophagicOFFSIDES
60HypophagiaOFFSIDES
61HypoxiaOFFSIDES
62Impaired gastric emptyingOFFSIDES
63InfectionOFFSIDES
64Infusion site infectionOFFSIDES
65Leukopenia neonatalOFFSIDES
66Lip erosionOFFSIDES
67Lymphocyte stimulation test positiveOFFSIDES
68Mesenteric vascular insufficiencyOFFSIDES
69Myoglobin urine presentOFFSIDES
70OverdoseOFFSIDES
71Percutaneous Coronary InterventionOFFSIDES
72PeritonitisOFFSIDES
73PneumothoraxOFFSIDES
74Protein total decreasedOFFSIDES
75Prothrombin level decreasedOFFSIDES
76Pupillary light reflex tests abnormalOFFSIDES
77Rebound effectOFFSIDES
78Respiratory FailureOFFSIDES
79Right ventricular systolic pressure increasedOFFSIDES
80SequestrectomyOFFSIDES
81Stevens-Johnson SyndromeOFFSIDES
82StridorOFFSIDES
83Thrombotic strokeOFFSIDES
84Upper respiratory tract inflammationOFFSIDES
85Urine osmolarity increasedOFFSIDES
86Urobilin urine presentOFFSIDES
87Vascular calcificationOFFSIDES
88Ventricular FibrillationOFFSIDES
89White blood cell count abnormalOFFSIDES
90Wound InfectionOFFSIDES
91YawningOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120295

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.